Swiss public-health groups forced Philip Morris International to abandon a planned 700-square-meter IQOS flagship store in Lausanne in 2018 after a coalition used political pressure, independent research and legal challenges to block indoor use of the heated-tobacco product, Génération Sans Tabac reported, according to Génération sans tabac.
The case study, published November 16 in Swiss Medical Weekly by researchers Valérie Ballmer, Karin Zürcher and Léa Lebon of the University of Lausanne, traces how a 2016 proposal for a combined boutique, café and event space became a test of whether Switzerland’s tobacco-friendly regulatory framework could be challenged, Génération Sans Tabac reported.
Switzerland hosts PMI’s operational headquarters in Lausanne and its research center in Neuchâtel, and the country was among the first markets for IQOS after Japan in 2015.
PMI marketed IQOS as a “reduced-risk” alternative that produced aerosol rather than smoke, a distinction that allowed lighter health-warning and tax rules despite retail prices comparable to cigarettes, the study says. Public-health researchers countered that the aerosol contained toxicants similar to cigarette smoke and that marketing tied tobacco use to technology and lifestyle through festivals, pop-up shops and sponsorships.
The flagship-store project intensified the conflict in 2016. The Association Pulmonaire Vaudoise coordinated opposition to the building permit, while researchers submitted preliminary findings on IQOS emissions to cantonal authorities. In 2017, authorities granted the permit but banned heated-tobacco use indoors except in enclosed smoking rooms, citing the precautionary principle and available emissions data, the study says.
Formally published research in 2017 confirmed toxicants in IQOS aerosol; PMI criticized the study and sought its retraction without success, a move the authors link to the industry’s history of pressuring researchers.
PMI withdrew the flagship plan in 2018, citing “purely commercial reasons” before a court ruling, which public-health groups treated as a victory. A smaller, 124-square-meter store opened in another Lausanne district in 2019 complying with the indoor ban, though the authors say its symbolic impact was reduced by the less strategic location.
The study argues that Switzerland’s failure to ratify the WHO Framework Convention on Tobacco Control, signed in 2004, limited stronger national policies, while France’s comprehensive legislation and civil-society jurisprudence have so far blocked similar IQOS development.
From 2019, novel nicotine products such as e-cigarettes and nicotine pouches expanded in regulatory gaps, prompting cantonal and federal law revisions by 2024 to cover those products, with an exception for medical devices. Since 2025, advertising has been banned in shops accessible to minors in the canton of Vaud.
The University of Lausanne, where the study’s authors are based, was founded in 1537 as a school of Protestant theology and became a university in 1890. It is the second-oldest university in Switzerland and one of the oldest in continuous operation worldwide.
As of fall 2017, about 15,000 students and 3,300 employees studied and worked there. Together with the École polytechnique fédérale de Lausanne, it forms a vast campus on the shores of Lake Geneva.
The authors recommend continuous monitoring of industry innovations, broad and anticipatory legislation, independent research to counter industry-funded narratives, and coalitions linking scientific expertise, evidence-based advocacy and political action. A 2025 Unisanté survey in French-speaking Switzerland found 90 percent of respondents believed the state must better protect youth from tobacco-industry strategies, and 88 percent said industry economic interests must not override public health, Génération Sans Tabac reported.